Details for New Drug Application (NDA): 019961
✉ Email this page to a colleague
The generic ingredient in GANITE is gallium nitrate. There are sixteen drug master file entries for this compound. Additional details are available on the gallium nitrate profile page.
Summary for 019961
Tradename: | GANITE |
Applicant: | Chapter 7 Trustee |
Ingredient: | gallium nitrate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jan 17, 1991 | TE: | RLD: | No |
Expired US Patents for NDA 019961
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chapter 7 Trustee | GANITE | gallium nitrate | INJECTABLE;INJECTION | 019961-002 | Jan 17, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription